trypan blue
MEMBRANEBLUE (trypan blue) is membraneblue 0. First approved in 2009.
Drug data last refreshed 5h ago · AI intelligence enriched 2d ago
MembraneBlue (trypan blue 0.15%) is an ophthalmic solution that selectively stains internal ocular membranes during posterior eye surgery. It is used intraoperatively to visualize epiretinal membranes (ERM) and internal limiting membranes (ILM) to improve surgical precision. The dye enhances membrane visualization without affecting tissue function.
Moderate competitive pressure (30%) suggests established market presence, but LOE approaching indicates team contraction and shift toward retention-focused strategies.
MembraneBlue 0.15% - Mechanism of action section. MembraneBlue 0.15% selectively stains membranes in the human eye during posterior surgery, such as epiretinal membranes (ERM) and Internal Limiting Membranes (ILM).
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
MembraneBlue offers limited near-term career growth given zero linked job openings and LOE-approaching status; however, it provides stable revenue and surgical market expertise. Roles focus on protecting market share and managing distributor relationships in a mature, niche surgical product category.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.